Emerging data are reshaping how clinicians match patients to therapy
— Emerging data are reshaping how clinicians match patients to therapy
by Gregory Laub, Senior Director, Video, MedPage Today
May 29, 2026
• 2 min read
As discussions at the American Academy of Dermatology annual meeting emphasized advances in chronic spontaneous urticaria (CSU), evolving research is challenging the long-held view of the disease as primarily driven by immunoglobulin E (IgE).
‘Dozens’ of treatments for chronic itch under investigation
Patients with autoimmune rheumatic disease exhibit persistent COVID antigen positivity
Ophthalmology | Practice Management News | Healio
Medical Dermatology Therapy Update
Sexual Health News
‘Stack’ biologics, hormonal therapies for optimal hidradenitis suppurativa outcomes
Understanding the potential of CAR-T therapy in autoimmune disease treatment
Joel M. Gelfand, MD, MSCE, FAAD
Biologics coordinators, ‘administrative complexity’ drive treatment choice in rheumatology
Apogee eczema drugs gets Blackstone backing, heads to Phase 3
CLEVELAND — After more than a decade with no new medications for chronic spontaneous urticaria, clinicians are beginning to see…
Food allergy management is shifting from passive strategies — such as avoidance, carrying epinephrine and hope — to proactive…
CLEVELAND — Researchers are beginning to understand the pathogenesis of dermatomyositis, leading to new, targeted therapies for…
CLEVELAND — For the first time in decades, targeted therapies to treat cutaneous lupus erythematosus are advancing through the…
Pyoderma gangrenosum is a difficult-to-treat wound disease that may soon have promising new therapies.In this Beneath the Surface…
Bryan Sauer, MD, MSc, and Rob are paid consultants for Takeda.
